West Pharmaceutical Services Balance Sheet Health
Financial Health criteria checks 6/6
West Pharmaceutical Services has a total shareholder equity of $2.7B and total debt of $206.2M, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are $3.6B and $921.7M respectively. West Pharmaceutical Services's EBIT is $668.3M making its interest coverage ratio -31.8. It has cash and short-term investments of $601.8M.
Key information
7.7%
Debt to equity ratio
US$206.20m
Debt
Interest coverage ratio | -31.8x |
Cash | US$601.80m |
Equity | US$2.68b |
Total liabilities | US$921.70m |
Total assets | US$3.60b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: W2ST34's short term assets ($1.7B) exceed its short term liabilities ($648.4M).
Long Term Liabilities: W2ST34's short term assets ($1.7B) exceed its long term liabilities ($273.3M).
Debt to Equity History and Analysis
Debt Level: W2ST34 has more cash than its total debt.
Reducing Debt: W2ST34's debt to equity ratio has reduced from 14.3% to 7.7% over the past 5 years.
Debt Coverage: W2ST34's debt is well covered by operating cash flow (366.9%).
Interest Coverage: W2ST34 earns more interest than it pays, so coverage of interest payments is not a concern.